Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

NCT06715501 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

20

Enrollment

NETWORK

Sponsor class

Conditions

Locally Advanced Esophageal Squamous Cell Carcinoma
II-IIIB Stages

Interventions

DRUG: Cadonilimab
RADIATION: radiotherapy
DRUG: carboplatin, paclitaxel

Sponsor

First Affiliated Hospital of Ningbo University